- Home
- products
- united kingdom
- testing services targeting to preclinical studies
Show results for
Refine by
Testing Services Targeting To Preclinical Studies Equipment Supplied In United Kingdom
14 equipment items found
Manufactured by:AstraZeneca based inCambridge, UNITED KINGDOM
IVX-121 targets respiratory syncytial virus (RSV), a major cause of viral pneumonia for which no vaccine has been FDA approved. IVX-121 incorporates a stabilized prefusion F antigen licensed from NIAID/NIH (DS-Cav1; Science 2019). RSV F is known to undergo major structural changes that allow viral entry into the host cell, and during that process, critical protective epitopes are lost. Protein ...
Manufactured by:Wolfmet based inManchester, UNITED KINGDOM
Wolfmet 3D, developed by M&I Materials Ltd, leverages a sophisticated selective laser melting (SLM) technique for additive manufacturing. This process involves the use of a high-powered laser to meticulously fuse layers of pure tungsten powder. The result is the creation of highly intricate and precise components such as collimators and radiation shields used in medical imaging systems like ...
Manufactured by:Sequana Medical NV based inSint-Denijs Westrem, BELGIUM
Direct Sodium Removal (DSR®) therapy is Sequana Medical’s novel and proprietary approach under development for the management of fluid overload due to heart failure. The sodium concentration in patients with fluid overload is in balance but there is too much sodium and too much fluid in the body. Sequana Medical’s approach is to remove excess sodium in patients with ...
Manufactured by:Camurus AB based inLund, SWEDEN
FluidCrysta nanoparticles can resolve bioavailability issues for water and lipid-soluble pharmaceuticals or biodegradation-sensitive drugs, such as peptides and proteins. FluidCrystal nanoparticles are usually water-based and comprise a stable emulsion of nanoparticles with a liquid crystalline structure. Investigational medicinal products based on this technology are administered either ...
Manufactured by:CN Bio based inCambridge, UNITED KINGDOM
Our Non-Alcoholic Fatty Liver Disorder (NAFLD)/NASH in vitro Services offer a preclinical tool to test therapeutics in a human-relevant model, replicating key disease phenotypes including fibrosis and reporting clinical biomarkers to allow translatability to clinical trials. ...
Manufactured by:Catalent, Inc based inSomerset, NEW JERSEY (USA)
The biologics market is experiencing high growth. However, the path to clinic for biologics is complex, requiring a substantial amount of time and resources to ensure success. Sponsor companies are looking for an “all of the above” solution, where they don’t have to trade speed for risk while managing multiple development partners. ...
Manufactured by:ReGen Therapeutics Limited based inLondon, UNITED KINGDOM
ReGen Therapeutics was formed in February 1998 to develop Colostrinin™, a proline-rich polypeptide complex derived from mammalian colostrum. The complex and the peptides within it are viewed as having potential utility in neurodegenerative illnesses such as Alzheimer’s disease, Parkinson’s Disease, Multiple Sclerosis and Amyotrophic Lateral ...
Manufactured by:Scancell based inOxford, UNITED KINGDOM
Scancell’s lead ImmunoBody cancer vaccine, SCIB1, is being developed for the treatment of patients with metastatic melanoma. SCIB1 incorporates specific epitopes from the proteins gp100 and TRP-2, which were identified from the cloning of T cells from patients who achieved spontaneous recovery from melanoma skin cancers. Both proteins play key roles in the production of melanin in the ...
Manufactured by:AstraZeneca based inCambridge, UNITED KINGDOM
IVX-A12 is a bivalent combination of IVX-121 and IVX-241, a human metapneumovirus (hMPV) VLP vaccine candidate. IVX-A12 is being designed to target both RSV and hMPV in a single vaccine candidate. hMPV is being increasingly recognized as a major contributor to acute respiratory infection and pneumonia with rates of pneumonia (Clinics in Chest Medicine 2017) and hospitalization (JID 2012) similar ...
Manufactured by:ClearPoint Neuro, Inc. based inIrvine, CALIFORNIA (USA)
The SmartFlow MR Compatible Ventricular Cannula has received 510(k) clearance from the FDA for use in the US for the aspiration of CSF, or injection of the chemotherapy drug Cytarabine into the ventricle. It has also been CE marked for use in Europe for the delivery of approved fluids into the brain or aspiration of CSF. It’s being utilized in approved clinical and preclinical studies for ...
Manufactured by:Bruker Corporation based inBillerica, MASSACHUSETTS (USA)
Designed for the emerging market of preclinical and molecular MR imaging: The BioSpec series is designed for the emerging market of preclinical and molecular MR imaging. State-of-the-art MRI CryoProbe technology together with ultra high field USR magnets deliver high spatial resolution in vivo enabling customers to come closer to the molecular and cellular level research they desire. Thanks to ...
Manufactured by:The Electrospinning Company Ltd. based inDidcot, UNITED KINGDOM
Cornea Regeneration on a synthetic membrane with limbal tissue explants. The University of Sheffield, in collaboration with the L.V.Prasad eye clinic in Hyderabad, developed corneal repair materials and procedures that offer a step change in availability and affordability. Phase I clinical trials have demonstrated patient safety. ...
Manufactured by:Adaptimmune LLC based inPhiladelphia, PENNSYLVANIA (USA)
Our goal is to revolutionize cancer therapy on a global basis by developing TCR T-cell therapies (called SPEAR T-cells) with the potential to treat a wide range of cancer types and patients. Our TCR T-cell therapies have advantages over other immune therapies and cancer therapies. The video below provides more ...
Manufactured by:Arterius Limited based inLeeds, UNITED KINGDOM
ArterioSorb is produced from the FDA approved polymer, PLLA, which is already universally approved for use in cardiovascular stents, sutures and orthopaedic applications. ArterioSorb is a tubular stent with closed-cell (with connectors for strength) and open-cell (with fewer connectors for flexibility) modules and increasing cell size as one moves away from the centre: The smaller cells at the ...